Author:
Karimi Saeed,Fakhri Nila,Ansari Iman,Hassanpour Kiana,Safi Sare
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA et al (2011) Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology 118(10):2028–2034
2. Nentwich MM, Yactayo-Miranda Y, Schwarzbach F, Wolf A, Kampik A, De Kaspar HM (2014) Endophthalmitis after intravitreal injection: decreasing incidence and clinical outcome—8-year results from a tertiary ophthalmic referral center. Retina 34(5):943–950
3. Mishra C, Lalitha P, Rameshkumar G, Agrawal R, Balne PK, Iswarya M et al (2018) Incidence of endophthalmitis after intravitreal injections: risk factors, microbiology profile, and clinical outcomes. Ocul Immunol Inflamm 26(4):559–568
4. Grzybowski A, Told R, Sacu S, Bandello F, Moisseiev E, Loewenstein A et al (2018) 2018 update on intravitreal injections: Euretina expert consensus recommendations. Ophthalmologica 239(4):181–193
5. Williams GA (2014) IVT injections: health policy implications. Rev Ophthalmol 21(6):62–64
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献